Status:
COMPLETED
Omphaloceles and Associated Malformations
Lead Sponsor:
University Hospital Tuebingen
Conditions:
Omphalocele
Eligibility:
All Genders
Up to 28 years
Brief Summary
Major birth defects like omphalocele are diagnosed in 3-8% of all newborns in Germany each year. Prevention and treatment quality of congenital malformations are key concerns for child health. Poor lo...
Detailed Description
An observational study using anonymized questionnaires, enrolled over two years (01/07/2019 - 30/06/2021) via the Surveillance Unit for Rare Pediatric Conditions in Germany (ESPED - Erhebungseinheit f...
Eligibility Criteria
Inclusion
- preterm and term newborns ≤ 28 days
- present omphalocele
Exclusion
- none
Key Trial Info
Start Date :
July 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
118 Patients enrolled
Trial Details
Trial ID
NCT04126863
Start Date
July 1 2019
End Date
June 30 2022
Last Update
October 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Neonatology
Tübingen, Germany, 72074